Physical Sciences Division
Published November 22, 2018 | Version v1
Patent Open

RECOMBINANT ANTIBODIES THAT RECONGNIZE THE C-TERMINAL DOMAINS OF EBOLA VIRUS NUCLEOPROTEIN

Creators

  • 1. University of Virginia
  • 2. University of Chicago

Contributors

Description

This disclosure is directed to compositions and methods for utilizing the boundaries of the C-terminal domains of Nucleoprotein from Zaire Ebola virus as highly stable recombinant protein antigens to generate antibodies for diagnosis and treatment of Ebola virus infection.

Files

US20180334494.pdf

Files (2.7 MB)

Name Size Download all
md5:4f8cf7573fed9a9522a20302d801764a
2.7 MB Preview Download

Additional details

Identifiers

Patent application number
US 201515518417 A
Patent number
US 2018/0334494 A1
Other
oai:uchicago.tind.io:8036

Dates

Patent filed
2015-10-16

UChicago Information

Division(s)
Physical Sciences Division
Department(s)
Physics